Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy

被引:116
|
作者
Li, Bing [1 ,2 ,3 ]
Liu, Shujun [2 ]
Miao, Lining [1 ]
Cai, Lu [3 ]
机构
[1] Jilin Univ, Dept Nephrol, Hosp 2, Changchun 130042, Peoples R China
[2] Jilin Prov Peoples Hosp, Dept Nephrol, Changchun 130041, Peoples R China
[3] Univ Louisville, KCHRI Pediat Diabet Res Labs, Dept Pediat, Louisville, KY 40202 USA
关键词
OXIDATIVE STRESS; BARDOXOLONE METHYL; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; CDDO-IMIDAZOLIDE; KIDNEY-FUNCTION; HYPERGLYCEMIA; DYSFUNCTION; RESVERATROL; TRITERPENOIDS;
D O I
10.1155/2012/216512
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic cardiomyopathy and nephropathy are two major causes of death of patients with diabetes. Extra generation of reactive oxygen species (ROS), induced by hyperglycemia, is considered as the main reason for the development of these diabetic complications. Transcription factor, NFE2-related factor 2 (Nrf2), is a master regulator of cellular detoxification response and redox status, and also provides a protective action from various oxidative stresses and damages. Recently we have demonstrated its important role in determining the susceptibility of cells or tissues to diabetes-induced oxidative stress and/or damage. Therefore, this review will specifically summarize the information available regarding the effect of Nrf2 on the diabetic complications with a focus on diabetic cardiomyopathy and nephropathy. Given the feature that Nrf2 is easily induced by several compounds, we also discussed the role of different Nrf2 activators in the prevention or therapy of various diabetic complications. These findings suggest that Nrf2 has a potential application in the clinic setting for diabetic patients in the short future.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice
    Zang, Huimei
    Wu, Weiwei
    Qi, Lei
    Tan, Wenbin
    Nagarkatti, Prakash
    Nagarkatti, Mitzi
    Wang, Xuejun
    Cui, Taixing
    DIABETES, 2020, 69 (12) : 2720 - 2734
  • [32] Resveratrol Prevents Diabetic Cardiomyopathy by Increasing Nrf2 Expression and Transcriptional Activity
    Wang, Guan
    Song, Xianjin
    Zhao, Lei
    Li, Zhibo
    Liu, Bing
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [33] Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy
    Ge, Zhi-Dong
    Lian, Qingquan
    Mao, Xiaowen
    Xia, Zhengyuan
    INTERNATIONAL HEART JOURNAL, 2019, 60 (03) : 512 - 520
  • [34] Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?
    Hall, Evan T.
    Bhalla, Vivek
    DIABETES, 2014, 63 (09) : 2904 - 2905
  • [35] NRF2 Activation in Diabetic Wound Healing: Comparison of Electrophilic and Non-Electrophilic NRF2 Activators
    Barakat, May
    Chen, Lin
    David, Brian P.
    Shi, Junhe
    Xu, Angela
    Skowron, Kornelia J.
    Johnson, Tatum
    Woods, Reginald
    Ankireddy, Aparna
    Reddy, Sekhar P.
    Moore, Terry W.
    DiPietro, Luisa A.
    WOUND REPAIR AND REGENERATION, 2022, 30 (05) : A35 - A35
  • [36] Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy
    Deliyanti, Devy
    Alrashdi, Saeed F.
    Tan, Sih Min
    Meyer, Colin
    Ward, Keith W.
    de Haan, Judy B.
    Wilkinson-Berka, Jennifer L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (02) : 815 - 825
  • [37] Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice
    Wu, Hongkui
    Liu, Gang
    He, Yaoli
    Da, Jing
    Xie, Bingqing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
  • [38] Prevention of Streptozotocin-Induced Diabetic Nephropathy by MG132: Possible Roles of Nrf2 and IκB
    Kong, Lili
    Wang, Yangwei
    Luo, Manyu
    Tan, Yi
    Cui, Wenpeng
    Miao, Lining
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [39] ND-13, a DJ-1 Derived Peptide, as a Novel Pharmacological Approach to Activated Nrf2 in the Prevention of Inflammasome Activation in Diabetic Nephropathy
    Cuevas, Santiago
    Sanchez, Virginia C.
    Luna Garcia, Adrian
    Kupchyk, Maksym
    Andugar-Rocamora, Leonor
    Lopez, Cristina M.
    Ros Madrid, Inmaculada
    Navarro, Laura H.
    Rosique, Florentina
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 118 - 118
  • [40] Therapeutic Potential of Nrf2 Activator Pterostilbene in Streptozotocin-induced Diabetic Nephropathy
    Mohanram, Ramkumar Kunka
    Elango, Bhakkiyalakshmi
    Dornadula, Sireesh
    Paulmurugan, Ramasamy
    DIABETES, 2016, 65 : A131 - A131